CoraLite® Plus 647 Anti-Human INSR/CD220 Rabbit Recombinant Antibody

INSR/CD220 Uni-rAbTM Recombinant Antibody for FC
Cat No. CL647-98227
Clone No.241687A10

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

FC

INSR, 241687A10, CD220, EC:2.7.10.1, HHF5

Formulation:  PBS and Azide
PBS and Azide
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive FC detected inhuman PBMCs

Recommended dilution

ApplicationDilution
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 ul per 10^6 cells in a 100 µl suspension or 5 ul per 100 µl of whole blood.
Sample-dependent, Check data in validation data gallery.

Product Information

CL647-98227 targets INSR/CD220 in FC applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen Recombinant protein Predict reactive species
Full Name INSR
GenBank Accession NumberBC117172
Gene Symbol INSR
Gene ID (NCBI) 3643
Conjugate CoraLite® Plus 647 Fluorescent Dye
Excitation/Emission Maxima Wavelengths654 nm / 674 nm
Form Liquid
Purification MethodProtein A purification
UNIPROT IDP06213
Storage Buffer PBS with 0.09% sodium azide and 0.5% BSA , pH 7.3
Storage ConditionsStore at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

Background Information

The biological effects of INS are mediated by a membrane-spanning cell surface receptor that has been shown to consist of disulfide-linked alpha-subunits (135 kDa) and beta-subunits (95 kDa) that are cleaved products of a common precursor. The binding of INS to the receptor extracellular domain results in intracellular activation of a tyrosine-specific kinase activity and the generation of signals that determine the cellular response (PMID: 2369896).

Protocols

Product Specific Protocols
FC protocol for CL Plus 647 INSR/CD220 antibody CL647-98227Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...